The global anti-snoring devices and snoring surgery market size was estimated over USD 903.8 Million in 2017 and is anticipated to gain significant traction over coming years. Snoring is the vibration of body respiratory system which results in sound while sleeping. This is due to air development during breathing while dozing or sleeping. In general, snoring is termed as a sleeping disorder produced because of monotonous collapsing and narrowing of the upper air route. Snoring have numerous adversative effects on health including systemic hypertension, stroke, coronary artery disease, and atrial fibrillation. Snoring may be caused due to obesity, obstruction of the nasal pathway due to high intake of drugs or alcohol, mis-positioned jaw, and throat weakness. Snoring is a common occurrence which can be cured or treated by the use of anti-snoring devices or by nasal surgery. Currently, more than 300 devices are registered in the U.S. Patent and Trademark Office providing the cure for snoring. On the other hand, surgeries for snoring includes Tonsillectomy and Adenoidectomy Surgery, Radiofrequency Ablation Surgery, Somnoplasty, Maxillo-mandibular, Uvulopalatopharyngoplasty Surgery and Genioglossus Advancement Surgeries.
Snoring is primarily caused owing to consumption of drugs, in order to relax throat muscles. According to World Drug Report 2016, approximately 247 people are consuming drugs globally. Furthermore, augmented consumption of alcohol by a person for over a period of time causes respiratory tract blockage leading to snoring while sleeping. In addition, obesity is one of the major reason for snoring. According to World Health Organization (WHO), in 2014, around 1.9 billion adults were reported to have overweight, of which over 600 million adults who were affected by obesity. Obesity causes a buildup of the fat nearby throat causing increase in the predominance of respiratory tract blockage. However, the removal of obese can be acquired by the laser-assisted surgeries, which in turn is anticipated to propel the market during the forecast period.
The global anti-snoring devices and snoring surgery market growth is driven by factors such as increasing demand for anti-snoring devices and growing number of pioneering devices available in the market. In addition, there is a growing demand for compact and low-cost devices. For instance, a company such as Airing LLC have launched battery-operated, disposable, and cordless micro-continuous positive airway pressure (CPAP) device in 2015 and such innovation is helping boost the demand for market. There is also an amplified demand for connected and wireless devices, on account of the rising dispersion of the internet of things (IoT). For instance, Medco Health has launched a telemedicine assistance system that not just monitors the sleeping pattern but also help schedule doctor’s appointments this product has helped patient suffering obstructive sleep apnea disorder.
However, lack of knowledge about appropriate treatment and the high cost of anti-snoring devices and surgeries are some of the factors hindering the global market growth.
The global anti-snoring devices and snoring surgery market are segmented on the basis of device type, surgical procedure, and geography.
On the basis of device type, the global market is categorized into oral applications, Nasal Dilator, Chin Strap, Position Control, Tongue Stabilizing Devices, and Expiratory Positive Airway Pressure. Among these segments, nasal products such as nasal strips and nasal cones are the most popular and widely used as these devices are easy to use and are convenient.
On the basis of surgery type the global market is further categorized into uvulopalatopharyngoplasty, laser-assisted uvulopalatoplasty, radiofrequency ablation, sclerotherapy, pillar procedure, and others. From the surgery type segment, somnoplasty is estimated as the fastest growing segment owing to factors such as minimally invasive, comparatively low surgery cost, less painful, and fewer complications in comparison to the conventional surgical procedures.
In terms of geography, the global anti-snoring devices and snoring surgery market are segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The key countries considered in the study are the U.S., Canada, Germany, UK, China, India, Brazil, Mexico, and South Africa.
North America is estimated to hold the dominant position in the market, due to the growing occurrence of snoring disorders in the region. For instance, according to American Sleep Foundation 2017, approximately 90 million American were estimated to be affected by one or the other respiratory disorder leading to snoring. As an outcome increasing the incidence of snoring is anticipated to increase the demand for its devices and treatment, fueling the market. The Asia Pacific is anticipated to dominate the market in the forecast period, owing to growing number of people suffering obesity and respiratory ailments, leading to augment the growth of the global market during the forecast period.
Major firms are focusing on small firms with a working methodology of securing the end goal to manage a position in the market and are associated with mergers and acquisitions, key joint efforts, and novel item advancement to pick up profit share in the business. Some major key players in the global market includes Apnea Sciences Corporation, Pure Sleep Company, SomnoMed Ltd., Airway Management, Inc., Theravent, Inc., Tomed Dr. Toussaint Gmbh, Glaxosmithkline Plc, and Meditas Ltd., among others.